H. Schlag

437 total citations
22 papers, 335 citations indexed

About

H. Schlag is a scholar working on Surgery, Hepatology and Molecular Biology. According to data from OpenAlex, H. Schlag has authored 22 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Hepatology and 6 papers in Molecular Biology. Recurrent topics in H. Schlag's work include Organ Transplantation Techniques and Outcomes (8 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Liver Disease and Transplantation (5 papers). H. Schlag is often cited by papers focused on Organ Transplantation Techniques and Outcomes (8 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Liver Disease and Transplantation (5 papers). H. Schlag collaborates with scholars based in Germany. H. Schlag's co-authors include Christine Lücke‐Huhle, H. Lobeck, Wolf O. Bechstein, P. Neuhaus, Jan M. Langrehr, P. Lemmens, K. F. Weibezahn, Matthias Wiens, G. Blumhardt and H. Keck and has published in prestigious journals such as Transplantation, International Journal of Radiation Biology and Clinical Transplantation.

In The Last Decade

H. Schlag

20 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Schlag Germany 10 153 130 105 55 52 22 335
T. Besse Belgium 11 127 0.8× 54 0.4× 23 0.2× 36 0.7× 24 0.5× 21 317
F. P. Stuart United States 7 82 0.5× 114 0.9× 28 0.3× 54 1.0× 33 0.6× 16 333
Yoshio Yamaoka Japan 12 312 2.0× 51 0.4× 268 2.6× 70 1.3× 94 1.8× 19 436
Xiaoshun He China 13 255 1.7× 91 0.7× 213 2.0× 64 1.2× 107 2.1× 46 432
Dora Ninova United States 8 187 1.2× 198 1.5× 17 0.2× 33 0.6× 22 0.4× 12 345
Todd Merchen United States 7 115 0.8× 27 0.2× 124 1.2× 61 1.1× 40 0.8× 16 407
Rafik Ghobrial United States 9 125 0.8× 110 0.8× 11 0.1× 82 1.5× 24 0.5× 16 394
Ashesh P. Shah United States 12 227 1.5× 205 1.6× 167 1.6× 63 1.1× 101 1.9× 31 460
R.A. Sidner United States 9 208 1.4× 51 0.4× 15 0.1× 59 1.1× 17 0.3× 28 322
J. Wohlschläger Germany 10 99 0.6× 32 0.2× 50 0.5× 44 0.8× 23 0.4× 23 284

Countries citing papers authored by H. Schlag

Since Specialization
Citations

This map shows the geographic impact of H. Schlag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Schlag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Schlag more than expected).

Fields of papers citing papers by H. Schlag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Schlag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Schlag. The network helps show where H. Schlag may publish in the future.

Co-authorship network of co-authors of H. Schlag

This figure shows the co-authorship network connecting the top 25 collaborators of H. Schlag. A scholar is included among the top collaborators of H. Schlag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Schlag. H. Schlag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Langrehr, J. M., Matthias Glanemann, Olaf Guckelberger, et al.. (1998). A randomized, placebo‐controlled trial with anti‐interleukin‐2 receptor antibody for immunosuppressive induction therapy after liver transplantation. Clinical Transplantation. 12(4). 303–312. 23 indexed citations
2.
Glanemann, Matthias, Jan M. Langrehr, Olaf Guckelberger, et al.. (1998). Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantation. Transplantation Proceedings. 30(5). 2159–2160. 7 indexed citations
3.
Langrehr, Jan M., Matthias Glanemann, Ulf P. Neumann, et al.. (1998). A Randomized Trial Comparing Anti-Interleukin-2 Receptor Antibody and Placebo for Immunosuppressive Therapy After OLT. Transplantation Proceedings. 30(4). 1445–1446. 6 indexed citations
4.
Glanemann, Matthias, Olaf Guckelberger, J Klupp, et al.. (1998). A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation.. PubMed. 12(4). 303–12. 27 indexed citations
5.
6.
Neuhaus, P., Wolf O. Bechstein, G. Blumhardt, et al.. (1993). COMPARISON OF QUADRUPLE IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION WITH ATG OR IL-2 RECEPTOR ANTIBODY. Transplantation. 55(6). 1320–1327. 98 indexed citations
7.
Keck, H., Wolf O. Bechstein, G. Blumhardt, et al.. (1993). Quadruple induction immunosuppression after liver transplantation with IL-2 receptor antibody (BT 563) is equally effective and better tolerated than ATG induction therapy.. PubMed. 25(1 Pt 1). 587–9. 3 indexed citations
8.
Neuhaus, P., Wolf O. Bechstein, G. Blumhardt, et al.. (1993). Quadruple induction immunosuppression after liver transplantation with interleukin-2 receptor antibody (BT 563) is equally effective and better tolerated than antithymocyte globulin induction therapy.. PubMed. 25(2). 1940–1.
9.
Leimenstoll, G., et al.. (1993). Cytokine secretion capacity of mononuclear cells in renal transplant recipients: the effect of two different dose schedules.. PubMed. 25(4). 2666–8. 1 indexed citations
10.
Otto, G., Jochen Thies, Dieter Kabelitz, et al.. (1991). Anti-CD25 monoclonal antibody prevents early rejection in liver transplantation--a pilot study.. PubMed. 23(1 Pt 2). 1387–9. 12 indexed citations
11.
Pawelec, Graham, U. Schwuléra, Heinz‐Josef Lenz, et al.. (1990). Lymphokine release, suppressor cell generation, cell surface markers, and cytotoxic activity in cancer patients receiving natural interleukin-2.. PubMed. 2(1). 44–9. 6 indexed citations
12.
Schlag, H., et al.. (1982). [Controlled double-blind study for the determination of the effect of Tebonin forte in patients with cerebrovascular insufficiency].. PubMed. 100(31-32). 1474–8. 14 indexed citations
13.
Schlag, H. & Christine Lücke‐Huhle. (1981). The Influence of Ionization Density on the DNA Synthetic Phase and Survival of Irradiated Mammalian Cells. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine. 40(1). 75–85. 15 indexed citations
14.
Lücke‐Huhle, Christine & H. Schlag. (1979). Differential radiosensitivity of two mammalian cell lines after hyperthermic pretreatment.. PubMed. 155(9). 649–54. 1 indexed citations
15.
Schlag, H., K. F. Weibezahn, & Christine Lücke‐Huhle. (1978). Negative Pion Irradiation of Mammalian Cells. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine. 33(1). 1–10. 15 indexed citations
16.
Dertinger, H., Christine Lücke‐Huhle, H. Schlag, & K. F. Weibezahn. (1976). Negative Pion Irradiation of Mammalian Cells. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine. 29(3). 271–277. 15 indexed citations
17.
Schlag, H. & Christine Lücke‐Huhle. (1976). Cytokinetic studies on the effect of hyperthermia on Chinese hamster lung cells. European Journal of Cancer (1965). 12(10). 827–831. 32 indexed citations
18.
Schlag, H., et al.. (1954). [Therapy of arterial hypertension with cation exchangers].. PubMed. 9(10). 224–5. 1 indexed citations
19.
Schlag, H., et al.. (1951). [Modern therapy of pernicious anemia].. PubMed. 6(26). 618–20. 2 indexed citations
20.
Schlag, H. & Irene Boll. (1951). [Effect of estradiol on the bone marrow cells in vitro].. PubMed. 6(47). 1116–19. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. Besse Breakdown of academic impact, for papers by F. P. Stuart Breakdown of academic impact, for papers by Yoshio Yamaoka Breakdown of academic impact, for papers by Xiaoshun He Breakdown of academic impact, for papers by Dora Ninova Breakdown of academic impact, for papers by Todd Merchen Breakdown of academic impact, for papers by Rafik Ghobrial Breakdown of academic impact, for papers by Ashesh P. Shah Breakdown of academic impact, for papers by R.A. Sidner Breakdown of academic impact, for papers by J. Wohlschläger
Rankless by CCL
2026